Claire Thomas
Directeur/Bestuurslid bij REBUS HOLDINGS, INC.
Vermogen: - $ op 31-12-2023
Actieve functies van Claire Thomas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REBUS HOLDINGS, INC. | Directeur/Bestuurslid | 12-10-2016 | - |
| Independent Dir/Board Member | 12-10-2016 | - | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Directeur/Bestuurslid | - | - |
Loopbaan van Claire Thomas
Eerdere bekende functies van Claire Thomas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31-07-2013 | 30-06-2016 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-08-2008 | 01-01-2013 |
Opleiding van Claire Thomas
| University of Illinois | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Japan | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Claire Thomas
- Ervaring